Abigail Marie the Chef with IBD
Professional Chef with IBD helping you navigate food, lifestyle, new IBD research, and patient advocacy.
With its FDA approval in August of 2019, Rinvouq began being prescribed for those with moderate to severe Rheumatoid Arthritis (RA). While many have seen improvement in symptoms, it has recently been found to be effective in treating another autoimmune disease; Ulcerative Colitis. Both RA and UC are built around inflammation triggered from the immune … Read more
As more and more advances in science and medicine are made, we are seeing more promising drugs in the making for those with Crohn’s and Colitis. One of these is a new drug class called S1P receptor modulators. S1P stands for Sphingosine 1 phosphate. This is a bioactive mediator that is responsible for regulation of … Read more
While COVID-19 rages across the globe in this unprecedented pandemic that has drug on for almost a year, hundreds of thousands of people globally are still wondering how this could impact their IBD. Here is what Dr. Gil Y. Melmend MD, MS co-director of the Inflammatory Bowel Disease Center in Los Angeles, California had to … Read more
While 2020 was challenging to say the least, we did see positives in the advancement of treatments for patients with ulcerative colitis. This comes as welcome news for many, with about 38,000 people a year diagnosed with UC. From new biologics, topical medicines, and immune modulators, ever growing research is supporting these treatments and more. … Read more
If you’re new to the world of IBD it may be confusing to differentiate IBD from IBS. They are after all both known to cause gut chaos, abdominal pain, and have a varying degree of severity depending on the person. This is however where the similarities end. In the following paragraphs we will cover their … Read more
Researchers at The University of Texas at Dallas, funded by the Crohn’s & Colitis Foundation, have designed a wrist watch-like device that monitors two important biomarkers associated with IBD flare ups through sweat. Having these two biomarkers present doesn’t necessarily mean the patient will flare, but it can give the chance to intervene earlier making … Read more
With the New Year here and in full swing, the produce section of your local store is in the back of most people’s mind. Goodluck finding kale this week! I wanted to take this opportunity to share some produce secrets with you. Fresh fruits and vegetables are an important part of the SCD diet, and … Read more
As more and more drugs come to market for autoimmune disorders the market gets fiercer and demanding. The current sweet spot? Taking autoimmune therapies from intravenous to pill form. This is seen across a wide range of autoimmune diseases from Multiple Sclerosis (MS) to IBD and everything in between. Zeposia was FDA approved for treatment … Read more
The question I most often hear after the holidays is “What’s your New Year’s resolution?” This is often the only time of year we assess our lives and make goals for our future. We put so much pressure on a goal or lifestyle fixed on this date of January 1st. While the new year does … Read more
Xeljanz (tofacitinib) is the first FDA approved biologic pill. Other current biologics require intravenous infusion or injection, so the convenience of a pill could be life changing to treat those with moderate to severe UC. This medication first was approved in 2019, and has been under close watch by health care professionals and the IBD … Read more